Skip to main content
Premium Trial:

Request an Annual Quote

Preconception Genetic Testing Firm GenePeeks Secures $3M Loan

NEW YORK (GenomeWeb) – Horizon Technology Finance said this week that it closed a $3 million loan to preconception genetic testing firm GenePeeks.

GenePeeks has offices in New York City and Cambridge, Mass., and focuses on identifying inherited disease risk in future generations. According to Horizon, the firm uses algorithms to simulate the genetic interactions between two potential parents that occur in reproduction, digitally crating and analyzing thousands of hypothetical genomes to discover disease risk that cannot be uncovered by existing pre-pregnancy screening tools.

GenePeeks' initial focus is on the sperm donor industry. In late May, the company launched its sperm donor screening service called Matchright with two partner sperm banks, as Clinical Sequencing News reported at the time. The service combines sequence data from potential sperm donors with sequence data from a female customer to create virtual gametes and then hundreds of thousands of virtual progeny, each with their own virtual genotype. Based on whether any of the genotypes could confer a disease phenotype, donors are ruled in or out, creating a low-risk catalogue for customers of the service.

In late 2012, GenePeeks raised $3 million in a Series A financing round.

"The growth capital with attractive terms provided by Horizon helps to unlock our potential for impact at a very important stage for the company," GenePeeks CEO Anne Morriss said in a statement.

The Scan

Study Reveals Details of SARS-CoV-2 Spread Across Brazil

A genomic analysis in Nature Microbiology explores how SARS-CoV-2 spread into, across, and from Brazil.

New Study Highlights Utility of Mutation Testing in Anaplastic Thyroid Cancer

Genetic mutations in BRAF and RAS are associated with patient outcomes in anaplastic thyroid carcinoma, a new JCO Precision Oncology study reports.

Study Points to Increased Risk of Dangerous Blood Clots in COVID-19 Patients

An analysis in JAMA Internal Medicine finds that even mild COVID-19 increases risk of venous thromboembolism.

Y Chromosome Study Reveals Details on Timing of Human Settlement in Americas

A Y chromosome-based analysis suggests South America may have first been settled more than 18,000 years ago, according to a new PLOS One study.